Walleye Trading
CTMX icon

Walleye Trading’s CytomX Therapeutics CTMX Stock Holding History

Walleye Trading’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-34,726
Closed -$289K – 4055
2019
Q4 		$289K Buy
+34,726
New +$234K ﹤0.01% 2854
2019
Q2 		– Sell
-10,200
Closed -$110K – 4104
2019
Q1 		$110K Buy
+10,200
New +$151K ﹤0.01% 3416
2018
Q4 		– Sell
-2,500
Closed -$46K – 4735
2018
Q3 		$46K Buy
+2,500
New +$57K ﹤0.01% 4583

Other funds holding CTMX

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Trading's CTMX Position: Q1 2020 in Review

Walleye Trading sold out of CytomX Therapeutics (CTMX) in Q1 2020, closing a stake of 34,726 shares — an estimated $289K sold.

Walleye Trading first reported a position in CTMX in Q3 2018 and held it in 3 quarters. The position peaked at $289K in Q4 2019. 117 funds tracked by Wall St. Rank hold CTMX as of Q1 2020.

  • Walleye Trading reported no remaining CytomX Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Walleye Trading sold 34,726 CytomX Therapeutics shares in Q1 2020, an estimated $289K.
  • Walleye Trading first reported a position in CytomX Therapeutics in Q3 2018 and held it in 3 quarters.
  • Walleye Trading's CytomX Therapeutics position peaked at $289K in Q4 2019.
  • 117 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.